- Why COVID-19 causes hair loss — and how to cope – NPR: Dr. Paradi Mirmirani says that people with COVID-19 may lose hair. Hair stylist Rebecca Haehnle says that people with thinning hair can use different styles and products.
- China has reopened its borders to tourists after three years of … – NPR: Cheung Seng-bun was one of the first in line at the reopening of the border crossing points between Hong Kong and mainland China. The border restrictions were imposed almost three years ago, but travelers from abroad are no longer required to undergo quarantines. The virus continues to spread in China, but Beijing is criticized for a lack of transparency.
- China’s Pandemic Disaster Isn’t A Win for Democracy – Foreign Policy: China’s President Xi Jinping boasted how the country’s handling of COVID-19 showed the superiority of its political system. But now the virus is raging out of control there, with estimates of 1-2 million deaths in the next 6 months.
- The Solution To Long-Haul COVID Could Now Come Out Of Traverse City – Traverse City Ticker: A game-changing treatment for COVID-19 could soon be one of northern Michigan’s most valuable exports. Bruce Patterson, M.D., the CEO and founder of IncellDx, Inc., has relocated from Silicon Valley to northern Michigan. IncellDx is at the cutting edge of multiple types of disease diagnostics and therapeutics – including COVID-19.
- Long COVID stemmed from mild cases of COVID-19 in most people, according to a new multicountry study – WANE: COVID-19 can have long-lasting effects on people’s health, even if it is a mild case. A new study published in the Journal of the American Medical Association found that 90% of people who have long COVID-19 (defined as the continuation or development of symptoms three months after the initial infection) experience symptoms for at least two months.
- Capital Region man battling effects of long COVID on how he is … – Spectrum News: Cases of COVID-19 are still rising, along with the flu and RSV. There is now a new variant, XBB.1.5, which spreads quickly and evades immunity from prior infections and the vaccine. It was first detected in India in August and has since spread to 17 countries, including the U.S.
- ‘I can no longer be an executive at a high level’: Workers with … – Morningstar: Dana Pollard, a 56-year-old man from Fort Worth, Texas, started a new job at the end of 2022, after spending three years recovering from a 2019 stroke. Pollard’s stroke caused him to lose recognition of his wife, have difficulty remembering things, and partially paralyze one side of his body. With physical and speech therapy, as well as medication, Pollard has been managing well. His previous job was as a director of canvassing, and his new position is as a canvassing manager at Tarran.
- Maryland doctors warn of contagious new COVID variant – CBS News: A new COVID variant is spreading across the nation. The variant is called XBB 1.5 and it derives from the Omicron strain. This variant is more contagious.
- COVID XBB.1.5 subvariant: How bad it is, why it’s called ‘Kraken … – Mashable: There is a new subvariant of COVID, XBB.1.5, which is spreading quickly in the Northeast US. Hospitalizations are rising. The COVID technical lead for the WHO, Maria Van Kerkhove, said officials are worried about how quickly XBB.1.5 is spreading.
- What we know about the XBB.1.5 COVID variant sweeping the Northeast – The Hill: The XBB.1.5 omicron subvariant of COVID-19 is raising concerns of a potential surge in cases as it sweeps across the Northeast. This subvariant is highly transmissible, can more easily evade the immunity offered by vaccines or prior infections than past variants, and is likely to drive cases up around the country.
Daily News Pulse for January 29, 2023
Summary: Governor John Carney has tested positive for COVID-19 and is working from home. The 7-day average of new cases in Delaware is 135, with 158 hospitalizations. A new study has found that 71% of people with long COVID required medical treatment or were unable to work for six months or more. The FDA has withdrawn emergency use authorization for the COVID-19 antibody drug Evusheld due to its ineffectiveness against the Omicron variants now dominating the US.
